Amended safety assessment of Hypericum perforatum-derived ingredients as used in cosmetics.

about

Amended safety assessment of Hypericum perforatum-derived ingredients as used in cosmetics.

Item

http://www.wikidata.org/entity/Q38258277

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Amended safety assessment of H ...... redients as used in cosmetics.

@en

type

Item

label

Amended safety assessment of H ...... redients as used in cosmetics.

@en

prefLabel

Amended safety assessment of H ...... redients as used in cosmetics.

@en

P1476

Amended safety assessment of H ...... redients as used in cosmetics.

@en

P2093

Curtis D Klaassen

http://www.w3.org/2001/XMLSchema#string

Donald V Belsito

http://www.w3.org/2001/XMLSchema#string

F Alan Andersen

http://www.w3.org/2001/XMLSchema#string

James G Marks

http://www.w3.org/2001/XMLSchema#string

Lillian C Becker

http://www.w3.org/2001/XMLSchema#string

Paul W Snyder

http://www.w3.org/2001/XMLSchema#string

Ronald A Hill

http://www.w3.org/2001/XMLSchema#string

Ronald C Shank

http://www.w3.org/2001/XMLSchema#string

Thomas J Slaga

http://www.w3.org/2001/XMLSchema#string

Wilma F Bergfeld

http://www.w3.org/2001/XMLSchema#string

P2860

Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine

Comparison of St John's wort and imipramine for treating depression: randomised controlled trial

Severe phototoxic reaction to laser treatment in a patient taking St John's Wort.

Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates.

Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

In vitro studies indicate that miquelianin (quercetin 3-O-beta-D-glucuronopyranoside) is able to reach the CNS from the small intestine.

Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study.

The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.

P304

5S-23S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1091581814533354

http://www.w3.org/2001/XMLSchema#string

P433

3 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel C. Liebler

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25297909

http://www.w3.org/2001/XMLSchema#string